FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Lundbeck poaches CEO from Wyeth ranks

Wanted: CEO who can find a new "cash cow" to push a Danish drugmaker past impending patent expirations. Found: Ulf Wiinberg, lately of Wyeth, to take over Lundbeck. Soon to be ex-president of Wyeth's operations in Europe, the Middle East, African and Canada, Wiinberg also had been charged with strategic oversight of Wyeth's biopharma. Can Wiinberg deliver for Lundbeck? No doubt we'll soon see what he can do.

- read Lundbeck's release
- check out the brief at Money AM
- see the item at PharmaGossip

Related Articles:
Lundbeck CEO resigns early
Lundbeck chair exits as company seeks calm

Lundbeck turns in promising depression data


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Wyeth   H. Lundbeck   patent expirations   Canada   Ulf Wiinberg   Europe